Symbols

Symbols

TLX

TLX

Telix Pharmaceuticals Investigation: Faruqi & Faruqi Encourages Investors to Contact Josh Wilson

Thursday Nov 13, 2025

Telix Pharmaceuticals Limited Faces Securities Fraud Class Action Lawsuit

Abroad Global Infrastructure Income Fund Q3 2025 Performance Review

Telix Pharmaceuticals faces securities class action, lead plaintiff deadline Jan. 9, 2026.

Wednesday Nov 12, 2025

Telix Pharmaceuticals Limited Securities Fraud Class Action Lawsuit: Investors Encouraged to Inquire

Tuesday Nov 11, 2025

Telix Pharmaceuticals Faces Class Action Lawsuit for Securities Law Violations

Telix Pharmaceuticals sued for securities fraud, class action filed.

Telix Pharmaceuticals Class Action Lawsuit Filed for Securities Violations

Telix Pharmaceuticals faces class action lawsuit over securities violations.

Monday Nov 10, 2025

Telix Pharmaceuticals Investors Sue Over Alleged Securities Fraud

Telix Pharmaceuticals Secures $105M in Funding, Raises 2023 Guidance to $60M

Wednesday Nov 05, 2025

Telix Pharmaceuticals to present at UBS Global Healthcare Conference and Jefferies Global Healthcare Conference.

Telix Pharmaceuticals to Participate in UBS and Jefferies Global Healthcare Conferences

Monday Nov 03, 2025

Telix Pharmaceuticals Securities Class Action Investigation Underway

Saturday Nov 01, 2025

Telix Pharmaceuticals faces SEC subpoena, investor investigation underway.

Saturday Oct 25, 2025

Telix Pharmaceuticals investigated for potential securities claims.

Telix Pharmaceuticals Investors May be Eligible for Compensation Through Securities Class Action Investigation

Tuesday Oct 21, 2025

IperionX's 15min chart triggers KDJ Golden Cross, bullish Marubozu formation.

Wednesday Oct 15, 2025

Telix Pharmaceuticals Limited shares jump 10.96% intraday after reporting 53% Q3 revenue growth and raising FY2025 sales guidance to $800M–$820M.

Tuesday Oct 14, 2025

Q3 2025 Commentary: TimesSquare U.S. Small Cap Growth Strategy